In addition, AC treatment dose-dependently inhibited the expression of 85 kDa Dvl (Dvl-2), an up-stream regulator of GSK3β in both B16F10 and B16F1 melanoma cells (Figure 2(a)). The gene discussed is GSK3B; the disease is melanoma.